TIMOPTIC Side Effects

6974443-6 | Aneurysm, Asthenopia, Dizziness, Eye Disorder, Eye Haemorrhage, Metamorphopsia, Nausea
on Aug 20, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: aneurysm (What is aneurysm?), asthenopia, dizziness (What is dizziness?), eye disorder, eye haemorrhage, metamorphopsia, nausea (What is nausea?). Timoptic dosage: . During the same period patient was treated with DORZOLAMIDE HYDROCHLORIDE (View Dorzolamide Hydrochloride Review and Dorzolamide Hydrochloride Label ), COSOPT (View Cosopt Review and Cosopt Label ).

6946768-1 | Accidental Overdose, Bradycardia, Cardiac Failure, Contusion, Dehydration, Ejection Fraction Decreased, Fall, Hyperkalaemia, Hypertensive Heart Disease
Patient was taking Timoptic (View Usage). Patient had the following side effects: accidental overdose, bradycardia, cardiac failure, contusion, dehydration, ejection fraction decreased, fall (What is fall?), hyperkalaemia, hypertensive heart disease on Aug 10, 2010 from FRANCE Additional patient health information: Female patient , 88 years of age, . Timoptic dosage: Opht. During the same period patient was treated with DIGOXIN (0.125 Mg/daily/po) (View Digoxin Review and Digoxin Label ), CORDARONE (200 Mg, Daily, Po) (View Cordarone Review and Cordarone Label ), INIPOMP (View Inipomp Review and Inipomp Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), LASIX (View Lasix Review and Lasix Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), STILLNOX (View Stillnox Review and Stillnox Label ). Patient was hospitalized.

6942316-0 | Pulmonary Embolism
Adverse event was reported on Aug 04, 2010 by a Female patient taking Timoptic (View Usage) (Dosage: Bid - 046) was diagnosed with ocular hypertension, open angle glaucoma and. Location: UNITED STATES , 67 years of age, After Timoptic was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd - 046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd - 046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), NAPROSYN (View Naprosyn Review and Naprosyn Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ), COREG (View Coreg Review and Coreg Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LOTREL (AMLODIPINE BESYLATE AND BENAZEPRIL HYDROCHLORIDE) (View Lotrel (amlodipine Besylate And Benazepril Hydrochloride) Review and Lotrel (amlodipine Besylate And Benazepril Hydrochloride) Label ). Patient was hospitalized.

6936748-4 | Atrial Fibrillation, Presyncope
on Aug 04, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with ocular hypertension, open angle glaucoma and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), presyncope. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), ACTONEL (View Actonel Review and Actonel Label ), COUMADIN (View Coumadin Review and Coumadin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.


6936730-7 | Ankle Fracture, Tendon Rupture
on May 12, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with glaucoma (What is glaucoma?), ocular hypertension and was treated with Timoptic (View Usage). Patient had the following side effects: ankle fracture, tendon rupture. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENAZEPRYL HCL/HCTZ (View Benazepryl Hcl/hctz Review and Benazepryl Hcl/hctz Label ). Patient was hospitalized.

6936606-5 | Ankle Fracture, Tendon Rupture
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: ankle fracture, tendon rupture on Jun 25, 2010 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with ocular hypertension, open angle glaucoma and. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd - 046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd - 046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), BENAZEPRYL HCL/HCTZ (View Benazepryl Hcl/hctz Review and Benazepryl Hcl/hctz Label ). Patient was hospitalized.

6932978-6 | Abnormal Weight Gain, Atrial Fibrillation, Blood Pressure Increased, Condition Aggravated, Dyspnoea, Oedema Peripheral, Sinus Bradycardia
Adverse event was reported on Jul 14, 2010 by a Male patient taking Timoptic (View Usage) (Dosage: Bid - 046) was diagnosed with ocular hypertension, open angle glaucoma and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: abnormal weight gain, atrial fibrillation (What is atrial fibrillation?), blood pressure increased, condition aggravated, dyspnoea, oedema peripheral, sinus bradycardia. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), FOLBEE (View Folbee Review and Folbee Label ), SKELAXIN (View Skelaxin Review and Skelaxin Label ), TIKOSYN (View Tikosyn Review and Tikosyn Label ), ZETIA (View Zetia Review and Zetia Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6931596-3 | Retinal Detachment
on Jul 21, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with glaucoma (What is glaucoma?), ocular hypertension and was treated with Timoptic (View Usage). Patient had the following side effects: retinal detachment. Timoptic dosage: Bid - 046;. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ), CHONDROITIN SULFATE SODIUM (View Chondroitin Sulfate Sodium Review and Chondroitin Sulfate Sodium Label ), GLUCOSAMINE SULFATE (View Glucosamine Sulfate Review and Glucosamine Sulfate Label ).

6929525-1 | Fall, Joint Dislocation
on May 28, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: fall (What is fall?), joint dislocation. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6929425-7 | Fall, Joint Dislocation
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), joint dislocation on Jul 28, 2010 from UNITED STATES Additional patient health information: Female patient , 56 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6929222-2 | Fall, Joint Dislocation
Adverse event was reported on May 28, 2010 by a Male patient taking Timoptic (View Usage) (Dosage: Bid - 046) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 56 years of age, Patient had the following side effects: fall (What is fall?), joint dislocation. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6925812-1 | Bradycardia, Cardiac Arrest, Dialysis, Left Ventricular Failure, Malaise, Shock
on Jul 21, 2010 Male patient from FRANCE , 61 years of age, was diagnosed with coronary artery disease (What is coronary artery disease?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: bradycardia, cardiac arrest (What is cardiac arrest?), dialysis (What is dialysis?), left ventricular failure, malaise, shock. Timoptic dosage: 2 Drops/daily/046. During the same period patient was treated with TAB IVABRADINE HYDROCHLORIDE (5mg/bid/047) (View Tab Ivabradine Hydrochloride Review and Tab Ivabradine Hydrochloride Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), ASPIRIN LYSINE (View Aspirin Lysine Review and Aspirin Lysine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), MEPROBAMATE (View Meprobamate Review and Meprobamate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ).

6883774-X | Pulmonary Embolism
on Jul 13, 2010 Female patient from UNITED STATES , 67 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd-046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), COREG (View Coreg Review and Coreg Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LOTREL (View Lotrel Review and Lotrel Label ), INDAPAMIDE (View Indapamide Review and Indapamide Label ). Patient was hospitalized.

6860818-2 | Hypoaesthesia, Retinal Vein Occlusion
Patient was taking Timoptic (View Usage). Patient had the following side effects: hypoaesthesia, retinal vein occlusion on Jul 16, 2010 from FRANCE Additional patient health information: Male patient , 72 years of age, was diagnosed with glaucoma (What is glaucoma?), hypertension, dental care and. Timoptic dosage: . During the same period patient was treated with DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE (View Dorzolamide Hydrochloride And Timolol Maleate Review and Dorzolamide Hydrochloride And Timolol Maleate Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), ARTICAINE HYDROCHLORIDE AND EPINEPHRINE (View Articaine Hydrochloride And Epinephrine Review and Articaine Hydrochloride And Epinephrine Label ).

6860221-5 | Fall, Joint Dislocation
Adverse event was reported on May 28, 2010 by a Male patient taking Timoptic (View Usage) (Dosage: Bid - 046) was diagnosed with ocular hypertension, open angle glaucoma and. Location: UNITED STATES , 56 years of age, After Timoptic was administered, patient had the following side effects: fall (What is fall?), joint dislocation. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (0.qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (0.qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (0.qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (0.qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6840317-4 | Retinal Detachment
on Jun 29, 2010 Female patient from UNITED STATES , 59 years of age, was diagnosed with glaucoma (What is glaucoma?), ocular hypertension and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: retinal detachment. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), CENTRUM SILVER (View Centrum Silver Review and Centrum Silver Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CALCIUM (View Calcium Review and Calcium Label ), CHONDROITIN SULFATE SODIUM (View Chondroitin Sulfate Sodium Review and Chondroitin Sulfate Sodium Label ).

6767413-4 | Accident, Fall, Joint Dislocation
on May 28, 2010 Male patient from UNITED STATES , 56 years of age, was diagnosed with ocular hypertension, open angle glaucoma and was treated with Timoptic (View Usage). Patient had the following side effects: accident, fall (What is fall?), joint dislocation. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6767409-2 | Arteriosclerosis Coronary Artery, Bundle Branch Block Right, Cardiomegaly, Electrocardiogram Low Voltage, Electrocardiogram Qt Prolonged, Electrocardiogram Repolarisation Abnormality, Electrocardiogram St Segment Elevation, Myocardial Infarction
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: arteriosclerosis coronary artery, bundle branch block right, cardiomegaly, electrocardiogram low voltage, electrocardiogram qt prolonged, electrocardiogram repolarisation abnormality, electrocardiogram st segment elevation, myocardial infarction on Jun 03, 2010 from UNITED STATES Additional patient health information: Female patient , 72 years of age, was diagnosed with ocular hypertension, open angle glaucoma and. Timoptic dosage: Bid - 046. During the same period patient was treated with TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), TAFLUPROST 0.0015% (MK 2452) (Qd -046) (View Tafluprost 0.0015% (mk-2452) Review and Tafluprost 0.0015% (mk-2452) Label ), BENICAR (View Benicar Review and Benicar Label ), CRESTOR (View Crestor Review and Crestor Label ), DYAZIDE (View Dyazide Review and Dyazide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6688557-1 | Alopecia, Deafness, Oedema Peripheral, Pruritus, Tinnitus
Adverse event was reported on Apr 15, 2010 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), intraocular pressure test abnormal and. Location: UNITED KINGDOM , 68 years of age, Patient experienced the following unwanted or unexpected effects: alopecia, deafness, oedema peripheral, pruritus, tinnitus (What is tinnitus?). During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), DORZOLAMIDE HYDROCHLORIDE (View Dorzolamide Hydrochloride Review and Dorzolamide Hydrochloride Label ).

6600513-8 | Hypertensive Crisis
on Feb 22, 2010 Female patient from AUSTRALIA , 87 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: hypertensive crisis. Timoptic dosage: . During the same period patient was treated with ROCURONIUM BROMIDE (View Rocuronium Bromide Review and Rocuronium Bromide Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ). Patient was hospitalized.

6580017-1 | Abdominal Pain, Dyspnoea, Hypotension, Malaise
on Feb 08, 2010 Female patient from FRANCE , 31 years of age, was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dyspnoea, hypotension, malaise. Timoptic dosage: . During the same period patient was treated with AMMONIUM GLYCYRRHIZATE AND ASCORBIC ACID AND CHLORHEXIDINE GLUCONATE A (View Ammonium Glycyrrhizate And Ascorbic Acid And Chlorhexidine Gluconate A Review and Ammonium Glycyrrhizate And Ascorbic Acid And Chlorhexidine Gluconate A Label ), ACONITE AND CODEINE AND ELECAMPANE AND SODIUM FORMATE (View Aconite And Codeine And Elecampane And Sodium Formate Review and Aconite And Codeine And Elecampane And Sodium Formate Label ), BIMATOPROST (View Bimatoprost Review and Bimatoprost Label ). Patient was hospitalized.

6488049-9 | Brain Stem Haemorrhage, Cerebral Haemorrhage, Pyrexia, Syncope
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: brain stem haemorrhage, cerebral haemorrhage, pyrexia, syncope on Dec 01, 2009 from JAPAN Additional patient health information: Female patient , 68 years of age, was diagnosed with intraocular pressure increased and. Timoptic dosage: One Drop In Each Eye. During the same period patient was treated with XALATAN (One Drop In Each Eye) (View Xalatan Review and Xalatan Label ). Patient was hospitalized.

6419778-0 | Bradycardia
Adverse event was reported on Jun 03, 2009 by a Male patient taking Timoptic (View Usage) (Dosage: Opht) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , 89 years of age, Patient had the following side effects: bradycardia. Patient was hospitalized.

6388931-7 | Acidosis, Rales, Respiratory Failure, Somnolence
on Sep 28, 2009 Female patient from FRANCE , 71 years of age, was diagnosed with angle closure glaucoma and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: acidosis, rales, respiratory failure, somnolence. Timoptic dosage: . During the same period patient was treated with ACETAZOLAMIDE (View Acetazolamide Review and Acetazolamide Label ), DEXAMETHASONE AND TOBRAMYCIN (View Dexamethasone And Tobramycin Review and Dexamethasone And Tobramycin Label ), CEFOTAXIME SODIUM (View Cefotaxime Sodium Review and Cefotaxime Sodium Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE (View Fluticasone Propionate And Salmeterol Xinafoate Review and Fluticasone Propionate And Salmeterol Xinafoate Label ), SINGULAIR (View Singulair Review and Singulair Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ). Patient was hospitalized.

6354896-7 | Extrapyramidal Disorder, Hallucination, Neuroleptic Malignant Syndrome
on Sep 01, 2009 Female patient from NORWAY , 89 years of age, was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: extrapyramidal disorder, hallucination, neuroleptic malignant syndrome. Timoptic dosage: . During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ).

6262797-8 | Frostbite, Nail Discolouration, Peripheral Ischaemia
Patient was taking Timoptic (View Usage). Patient had the following side effects: frostbite, nail discolouration, peripheral ischaemia on Jul 02, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 66 years of age, weighting 194.0 lb, was diagnosed with glaucoma (What is glaucoma?), sleep disorder (What is sleep disorder?), pain in extremity, prophylaxis and. Timoptic dosage: . During the same period patient was treated with AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), NAPROXEN (View Naproxen Review and Naproxen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TAMSULOSIN HYDROCHLORIDE (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ).

6196731-6 | Blood Pressure Decreased, Dizziness, Fatigue, Feeling Abnormal, Glaucoma, Heart Rate Decreased, Intraocular Pressure Increased, Palpitations
Adverse event was reported on May 14, 2009 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with glaucoma (What is glaucoma?), back pain (What is back pain?), arthritis (What is arthritis?), blood pressure (What is blood pressure?), intraocular pressure test and. Location: UNITED STATES , 90 years of age, weighting 141.1 lb, After Timoptic was administered, patient had the following side effects: blood pressure decreased, dizziness (What is dizziness?), fatigue, feeling abnormal, glaucoma (What is glaucoma?), heart rate decreased, intraocular pressure increased, palpitations. During the same period patient was treated with XALATAN (View Xalatan Review and Xalatan Label ), TRUSOPT (View Trusopt Review and Trusopt Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ), CELEBREX (View Celebrex Review and Celebrex Label ), VASERETIC (View Vaseretic Review and Vaseretic Label ), ALPHAGAN (View Alphagan Review and Alphagan Label ).

6193803-7 | Developmental Glaucoma, Disease Progression, Eye Haemorrhage
on May 05, 2009 Male patient from UNITED STATES , child 7 years of age, weighting 59.00 lb, was diagnosed with developmental glaucoma and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: developmental glaucoma, disease progression, eye haemorrhage. Timoptic dosage: 2 Drps/bid/opht. During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ). Patient was hospitalized.

6148314-1 | Abasia, Anorexia, Asthma, Blood Pressure Decreased, Diarrhoea, Eye Oedema, Eye Pruritus, Eyelid Exfoliation
on Apr 02, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). Patient had the following side effects: abasia, anorexia, asthma (What is asthma?), blood pressure decreased, diarrhoea, eye oedema, eye pruritus, eyelid exfoliation. Timoptic dosage: .

6143848-8 | Bradycardia, Extrasystoles
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: bradycardia, extrasystoles on Mar 26, 2009 from MEXICO Additional patient health information: Male patient , 80 years of age, . Timoptic dosage: .

6143840-3 | Photopsia
Adverse event was reported on Apr 01, 2009 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased and. Location: SPAIN , 70 years of age, Patient experienced the following unwanted or unexpected effects: photopsia.

6142141-7 | Bradycardia, Extrasystoles
on Mar 26, 2009 Male patient from MEXICO , 80 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: bradycardia, extrasystoles. Timoptic dosage: .

6102145-7 |
on Feb 12, 2009 Female patient from MEXICO , 65 years of age, was diagnosed with ocular hypertension and was treated with Timoptic (View Usage). . Timoptic dosage: .

6084102-2 |
Patient was taking Timoptic (View Usage). on Feb 12, 2009 from MEXICO Additional patient health information: Female patient , 65 years of age, was diagnosed with ocular hypertension and. Timoptic dosage: .

6071307-X | Photopsia
Adverse event was reported on Feb 04, 2009 by a Male patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased and. Location: SPAIN , 70 years of age, Patient had the following side effects: photopsia.

6011178-0 | Bone Disorder, Fatigue, Intraocular Pressure Increased
on Dec 15, 2008 Female patient from AUSTRALIA , 69 years of age, was diagnosed with intraocular pressure increased and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: bone disorder, fatigue, intraocular pressure increased. Timoptic dosage: .

6004447-1 | Stevens-johnson Syndrome
on Dec 09, 2008 Male patient from JAPAN , 60 years of age, was diagnosed with ocular hypertension, mydriasis, inflammation and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Timoptic dosage: . During the same period patient was treated with MYDRIN P (View Mydrin-p Review and Mydrin-p Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ). Patient was hospitalized.

5989188-9 | Stevens-johnson Syndrome
Patient was taking Timoptic (View Usage). Patient had the following side effects: stevens-johnson syndrome on Dec 04, 2008 from JAPAN Additional patient health information: Male patient , 60 years of age, was diagnosed with ocular hypertension, mydriasis, inflammation and. Timoptic dosage: . During the same period patient was treated with MYDRIN P (View Mydrin-p Review and Mydrin-p Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ). Patient was hospitalized.

5979644-1 | Corneal Epithelium Defect
Adverse event was reported on Dec 02, 2008 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with ulcerative keratitis and. Location: UNITED KINGDOM , 83 years of age, After Timoptic was administered, patient had the following side effects: corneal epithelium defect. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), OFLOXACIN (View Ofloxacin Review and Ofloxacin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ).

5942569-1 | Anterior Chamber Disorder, Intraocular Pressure Increased
on Oct 30, 2008 Male patient from UNITED KINGDOM , 27 years of age, was diagnosed with intraocular pressure increased and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: anterior chamber disorder, intraocular pressure increased. Timoptic dosage: . During the same period patient was treated with TRUSOPT (View Trusopt Review and Trusopt Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ).

5924668-3 | Accidental Overdose, Dry Eye, Eye Pain, Intraocular Pressure Increased, Myocardial Infarction
on Oct 10, 2008 Male patient from UNITED KINGDOM , 78 years of age, weighting 165.3 lb, was diagnosed with glaucoma (What is glaucoma?), ischaemic heart disease prophylaxis, myocardial ischaemia, dyspepsia, hypertension, lipids increased and was treated with Timoptic (View Usage). Patient had the following side effects: accidental overdose, dry eye, eye pain, intraocular pressure increased, myocardial infarction. Timoptic dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ).

5921331-X | Deafness
Patient was taking Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: deafness on Oct 14, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 50 years of age, was diagnosed with glaucoma (What is glaucoma?) and. Timoptic dosage: .

5899296-9 | Trabeculectomy, Vitrectomy
Adverse event was reported on Sep 23, 2008 by a Female patient taking Timoptic (View Usage) (Dosage: ) was diagnosed with intraocular pressure increased and. Location: UNITED KINGDOM , 29 years of age, Patient experienced the following unwanted or unexpected effects: trabeculectomy, vitrectomy. During the same period patient was treated with APRACLONIDINE (View Apraclonidine Review and Apraclonidine Label ), LATANOPROST (View Latanoprost Review and Latanoprost Label ).

5888641-6 | Hyphaema, Intraocular Lens Implant, Intraocular Pressure Increased, Iridocyclitis, Phacotrabeculectomy, Photocoagulation, Visual Acuity Reduced
on Sep 09, 2008 Female patient from UNITED KINGDOM , 25 years of age, was treated with Timoptic (View Usage). Patient had the following side effects: hyphaema, intraocular lens implant, intraocular pressure increased, iridocyclitis, phacotrabeculectomy, photocoagulation, visual acuity reduced. Timoptic dosage: . During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), PILOCARPINE (View Pilocarpine Review and Pilocarpine Label ), DORZOLAMIDE HYDROCHLORIDE (View Dorzolamide Hydrochloride Review and Dorzolamide Hydrochloride Label ).

5886497-9 | Keratopathy
on Sep 11, 2008 Female patient from UNITED KINGDOM , 43 years of age, weighting 130.1 lb, was diagnosed with glaucoma (What is glaucoma?), surgery (What is surgery?), dry eye and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: keratopathy. Timoptic dosage: . During the same period patient was treated with BETAMETHASONE SODIUM PHOSPHATE (View Betamethasone Sodium Phosphate Review and Betamethasone Sodium Phosphate Label ), CHLORAMPHENICOL (View Chloramphenicol Review and Chloramphenicol Label ), CARBOXYMETHYLCELLULOSE SODIUM (View Carboxymethylcellulose Sodium Review and Carboxymethylcellulose Sodium Label ). Patient was hospitalized and became disabled.

5884401-0 | Diplopia, Eyelid Disorder, Hydrocephalus, Ophthalmoplegia
Patient was taking Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, eyelid disorder, hydrocephalus (What is hydrocephalus?), ophthalmoplegia on Sep 05, 2008 from BRAZIL Additional patient health information: Female patient , 53 years of age, weighting 112.4 lb, was diagnosed with intraocular pressure test, blood pressure increased, diabetes mellitus and. Timoptic dosage: . During the same period patient was treated with AMLODIPINE BESYLATE AND ENALAPRIL MALEATE (View Amlodipine Besylate And Enalapril Maleate Review and Amlodipine Besylate And Enalapril Maleate Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5879650-1 | Amnesia
Adverse event was reported on Sep 11, 2008 by a Male patient taking Timoptic (View Usage) (Dosage: 1 Drop Each Eye Once A Day Ophthalmic) was diagnosed with glaucoma (What is glaucoma?) and. Location: UNITED STATES , weighting 185.0 lb, Patient had the following side effects: amnesia.

5877299-8 | Abasia, Anorexia, Asthma, Blood Pressure Decreased, Diarrhoea, Eye Oedema, Eye Pruritus, Eyelid Exfoliation, Fatigue
on Sep 04, 2008 Female patient from UNITED STATES , 72 years of age, was diagnosed with glaucoma (What is glaucoma?) and was treated with Timoptic (View Usage). After Timoptic was administered, patient had the following side effects: abasia, anorexia, asthma (What is asthma?), blood pressure decreased, diarrhoea, eye oedema, eye pruritus, eyelid exfoliation, fatigue. Timoptic dosage: .

5876740-4 | Diplopia, Eyelid Disorder, Hydrocephalus, Ophthalmoplegia
on Aug 13, 2008 Female patient from BRAZIL , 53 years of age, weighting 112.4 lb, was diagnosed with intraocular pressure test, blood pressure increased, diabetes mellitus and was treated with Timoptic (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia, eyelid disorder, hydrocephalus (What is hydrocephalus?), ophthalmoplegia. Timoptic dosage: . During the same period patient was treated with AMLODIPINE BESYLATE AND ENALAPRIL MALEATE (View Amlodipine Besylate And Enalapril Maleate Review and Amlodipine Besylate And Enalapril Maleate Label ), METFORMIN (View Metformin Review and Metformin Label ). Patient was hospitalized.

5874360-9 | Bradycardia, Loss Of Consciousness
Patient was taking Timoptic (View Usage). Patient had the following side effects: bradycardia, loss of consciousness on Sep 02, 2008 from JAPAN Additional patient health information: Male patient , 64 years of age, weighting 165.3 lb, was diagnosed with ocular hypertension and. Timoptic dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.